| Literature DB >> 30584255 |
Yuan Li1, Yong Guo2, Zhengshun Wen3, Xuemei Jiang1, Xin Ma1, Xinyan Han4.
Abstract
Weaned piglets are vulnerable to nutritional, physiological, and psychological stressors, leading to abrupt taxonomic and functional shifts in the intestinal microbiome. In this study, an integrated approach combination of 16S rDNA gene sequencing and the mass spectrometry-based metabolomics techniques was used to investigate the effects of weaning stress on intestinal microbial composition and its metabolic profiles of piglets. Three litters of suckling piglets with same parity were chosen. The samples of colonic contents were collected from each selected piglets (weaned day, 3 days after weaned) for microbial and metabolomics analysis. The results showed that Lachnospiraceae, Negativicutes, Selenomonadales, Campylobacterales and other 15 species increased after weaning, while Porphyromonadaceace, Alloprevotella, Barnesiella and Oscillibacter decreased. Based on the function profiles prediction and metabolomic analysis, five key metabolic pathways including Phenylalanine metabolism, Citrate cycle (TCA cycle), Glycolysis or Gluconeogenesis, Propanoate metabolism, Nicotinate and nicotinamide metabolism might be the relevant pathways involved in weaning stress-induced gut microbiota dysbiosis. Taken together, these results indicated that weaning stress not only changed microbial composition and function but altered the microbial metabolic profiles in the intestine, which might provide a new insight in alleviating weaning stress and facilitating disease prevention during the period of weaning in piglets.Entities:
Mesh:
Year: 2018 PMID: 30584255 PMCID: PMC6305375 DOI: 10.1038/s41598-018-33649-8
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1The overall structure of gut microbiota in nursing and weaned groups. (A), (B): Bacterial rarefaction curves based on Chao 1 and observed species index were used to assess the depth of coverage for each sample. (C) Venn diagram for bacterial OTUs compositions in two groups. (D) Similarity Analysis (Anosim Analysis) based on Unifrac algorithm. (E) Multiple sample similarity phylogenetic tree was built by Unweighted pair group method with arithmetic mean. Each sample was distinguished by different colors of lines. Blue and red represent nursing group and weaned group, respectively.
Richness and diversity of indices of colonic microbiota in nursing and weaned groups.
| Items | Richness indices | Diversity indices | |||
|---|---|---|---|---|---|
| Chao 1 | Observed species | PD_whole_tree | shannon | simpson | |
| nursing | 306.86 | 255.33 | 22.2 | 5.24 | 0.94 |
| weaned | 223.06 | 185.33 | 15.33 | 4.76 | 0.91 |
| p value | 0.03 | 0.03 | 8.66E−03 | 0.24 | 0.24 |
The coverage percentage, richness estimators (Chao1, Observed species), and diversity indices (PD_whole_tree, Shannon and Simpson) were calculated using the QIIME program. PD_whole_tree: (phylogenetic distance) whole tree.
Figure 2Gut microbial community structure in nursing and weaned groups. (A) Microbial community bar plot by phylum. (B) Microbial community bar plot by family. (C) Microbial community bar plot by genus. Each bar represents the average relative abundance of each bacterial taxon within a group. The top 20 abundant taxa are shown.
Figure 3Cladogram. Bacterial taxa significantly differentiated between Nursing and Weaned group identified by linear discriminant analysis coupled with effect size (LEfSe) using the default parameters.
Figure 4Predicted microbial function in the colon lumen of nursing and weaned groups. The third level of KEGG pathway was showed in the extended error bar. Blue and red represent nursing group and weaned group, respectively.
Figure 5PCA 3D OPLS-DA score plots and corresponding validation plots of OPLS-DA derived from the GC-TOF/MS metabolite profiles in the colon lumen of nursing and weaned piglets. (A) OPLS-DA score plots showed significantly separated clusters in nursing and weaned group. (B) Permutation test of OPLS-DA model of nursing and weaned group. Blue and red represent nursing group and weaned group, respectively.
Figure 6Volcano plot of nursing and weaned group. Each point represents a kind of metabolite, the scatter color represents the final screening result. Significant up-regulated metabolites are indicated in red, significantly down-regulated metabolites are indicated in blue, and non-significant differences in metabolites are grey.
Identified metabolites for discriminating between nursing and weaned groups based on the untargeted metabolomics study.
| Metabolic | Similarity | RTa (min) | MEAN -Weaned | MEAN -Nursing | VIP | t-testb |
|---|---|---|---|---|---|---|
|
| ||||||
| heptadecanoic acid | 828 | 20.337 | 5.57818E-11 | 0.000117 | 1.09225 | * |
| Sphingosine | 904 | 23.217 | 0.000373 | 0.004645 | 1.50233 | *** |
| phytosphingosine | 872 | 24.471 | 0.000206 | 4.89435E-11 | 1.31316 | ** |
| alpha-Tocopherol | 861 | 28.163 | 8.80993E-05 | 0.000391779 | 1.50347 | *** |
| Cholesterol | 899 | 28.352 | 0.002760734 | 4.89435E-11 | 1.31090 | ** |
| Cholestan-3beta-ol | 778 | 28.426 | 0.000120339 | 0.001103108 | 1.53157 | *** |
| Coprostan-3-one | 767 | 28.529 | 5.57818E-11 | 8.6931E-05 | 1.54168 | *** |
| Stigmasterol | 722 | 29.197 | 0.000277268 | 4.89435E-11 | 1.31269 | ** |
| L-Allothreonine | 929 | 12.201 | 0.000465693 | 0.008418029 | 1.53677 | *** |
| 2-Methylglutaric Acid | 866 | 12.596 | 5.57818E-11 | 0.000126571 | 1.54227 | *** |
| Capric Acid | 742 | 13.163 | 5.57818E-11 | 1.7529E-05 | 1.54125 | *** |
| lauric acid | 708 | 15.517 | 0.001545153 | 0.002149401 | 1.11408 | ** |
| Myristic acid | 850 | 17.694 | 0.000486967 | 0.040605731 | 1.54161 | *** |
| pentadecanoic acid | 759 | 18.671 | 0.002088078 | 0.017616468 | 1.41982 | ** |
| palmitoleic acid | 935 | 19.428 | 0.001754687 | 0.020718886 | 1.44486 | *** |
| stearic acid | 893 | 21.495 | 0.040239752 | 4.89435E-11 | 1.30941 | ** |
| Arachidic acid | 934 | 23.100 | 0.004225461 | 0.051756593 | 1.52418 | *** |
| Behenic acid | 951 | 24.606 | 0.002671156 | 0.033936219 | 1.51484 | *** |
| Lignoceric acid | 937 | 26.038 | 0.001859809 | 0.062046719 | 1.53010 | *** |
| Cerotinic acid | 902 | 27.387 | 0.000111121 | 0.001223183 | 1.50911 | *** |
|
| ||||||
| Lyxose | 828 | 15.414 | 0.001186306 | 9.8097E-05 | 1.51917 | *** |
| xylose | 953 | 15.589 | 0.031706877 | 0.002424436 | 1.51325 | *** |
| 6-deoxy-D-glucose | 807 | 16.220 | 0.000764127 | 0.000445482 | 1.34719 | ** |
| fructose | 900 | 17.856 | 0.000335583 | 0.000993779 | 1.49148 | *** |
| Sedoheptulose | 628 | 18.461 | 0.000268555 | 4.89435E-11 | 1.09879 | * |
| D-galacturonic acid | 864 | 18.579 | 0.000413546 | 4.89435E-11 | 1.31565 | ** |
| lactose | 708 | 25.021 | 0.00031404 | 1.14153E-05 | 1.01325 | *** |
| trehalose | 839 | 25.328 | 0.00033928 | 4.89435E-11 | 1.54237 | *** |
| maltose | 775 | 25.296 | 0.000274583 | 0.000162243 | 1.03989 | * |
|
| ||||||
| Pyruvic acid | 921 | 7.430 | 6.32753E-05 | 0.000116271 | 1.25376 | ** |
| glycolic acid | 930 | 7.829 | 0.007297916 | 0.000592752 | 1.45508 | ** |
| 3-Hydroxypropionic acid | 843 | 8.826 | 0.00325326 | 8.7607E-05 | 1.39673 | ** |
| glutaric acid | 708 | 12.458 | 0.001529942 | 0.000342019 | 1.28988 | ** |
| oxoproline | 950 | 13.968 | 0.04241735 | 0.082504831 | 1.38890 | *** |
|
| ||||||
| valine | 810 | 8.041 | 0.001631261 | 0.000197131 | 1.46254 | ** |
| Maleimide | 927 | 8.098 | 0.00013127 | 9.90848E-05 | 1.04632 | ** |
| sarcosine | 733 | 8.732 | 5.97859E-05 | 0.000118821 | 1.08313 | * |
| serine | 907 | 10.480 | 5.57818E-11 | 0.000131568 | 1.54214 | *** |
| Isoleucine | 841 | 10.923 | 0.000249148 | 8.0456E-06 | 1.35077 | ** |
| proline | 960 | 11.050 | 0.002575346 | 0.012998171 | 1.50201 | *** |
| glycine | 957 | 11.163 | 0.002625406 | 0.016532029 | 1.47505 | *** |
| beta-Alanine | 945 | 12.773 | 0.001489759 | 9.94769E-05 | 1.43201 | ** |
| aspartic acid | 956 | 13.927 | 0.00684775 | 0.015713239 | 1.25782 | *** |
| 4-aminobutyric acid | 844 | 14.067 | 0.007020642 | 0.000608468 | 1.51846 | *** |
| D-alanyl-D-alanine | 755 | 14.881 | 0.000863753 | 0.000171924 | 1.33635 | ** |
| asparagine | 865 | 15.681 | 5.57818E-11 | 0.000313104 | 1.30777 | ** |
| alpha-Aminoadipic acid | 806 | 16.208 | 0.000124128 | 4.9774E-06 | 1.35393 | *** |
| glutamine | 692 | 16.834 | 5.57818E-11 | 0.00042769 | 1.30790 | ** |
| ornithine | 940 | 17.323 | 0.001909938 | 0.00740552 | 1.48481 | *** |
| citrulline | 806 | 17.389 | 0.000271639 | 0.000529457 | 1.19390 | * |
| histidine | 833 | 18.369 | 5.57818E-11 | 0.00052798 | 1.09632 | * |
| tyrosine | 933 | 18.574 | 0.004176509 | 0.014777744 | 1.50781 | *** |
|
| ||||||
| m-Cresol | 681 | 8.987 | 2.3733E-05 | 0.000171394 | 1.44746 | *** |
| Catechol | 627 | 11.302 | 5.97445E-06 | 4.89435E-11 | 1.31768 | ** |
| phenylethylamine | 627 | 11.302 | 5.97445E-06 | 4.89435E-11 | 1.31768 | ** |
| Phenyllactate | 787 | 14.703 | 0.002295753 | 3.14665E-05 | 1.24267 | ** |
| gentisic acid | 611 | 16.852 | 3.101E-05 | 4.89435E-11 | 1.54228 | *** |
| tyramine | 846 | 18.329 | 0.014177717 | 4.89435E-11 | 1.30991 | ** |
| noradrenaline | 705 | 20.732 | 8.42385E-05 | 4.89435E-11 | 1.54199 | ** |
|
| ||||||
| Ethanolamine | 882 | 10.600 | 0.001545522 | 0.00042396 | 1.35263 | * |
| 1,3-diaminopropane | 928 | 15.449 | 0.001651697 | 0.000436322 | 1.25857 | ** |
| putrescine | 920 | 16.513 | 0.163908181 | 0.02821584 | 1.50530 | ** |
| spermine | 799 | 25.154 | 4.66359E-05 | 4.89435E-11 | 1.31451 | ** |
|
| ||||||
| 2-Furoic Acid | 604 | 8.695 | 2.60681E-05 | 4.89435E-11 | 1.54240 | ** |
| 5-aminovaleric acid lactam | 843 | 8.834 | 0.00394493 | 0.000152673 | 1.51907 | ** |
| nicotinic acid | 976 | 11.021 | 0.000714674 | 0.001438858 | 1.34719 | *** |
| Orotic acid | 635 | 16.509 | 5.57818E-11 | 7.6404E-05 | 1.08298 | * |
|
| ||||||
| N-Methyl-DL-alanine | 906 | 9.238 | 0.009567796 | 0.000546294 | 1.13615 | ** |
| Bis(2-hydroxypropyl)amine | 622 | 13.296 | 5.57818E-11 | 3.53733E-05 | 1.28973 | ** |
| Digitoxose | 727 | 15.012 | 5.57818E-11 | 5.96126E-05 | 1.09183 | ** |
| Cyclohexane-1,2-dione | 793 | 15.685 | 2.64145E-05 | 4.89435E-11 | 1.11298 | * |
| fucose | 958 | 16.319 | 0.005013265 | 0.010654332 | 1.46744 | *** |
| Methyl-beta-D-galactopyranoside | 650 | 17.678 | 0.000220863 | 0.001169638 | 1.46330 | *** |
| fructose | 840 | 17.954 | 0.000134698 | 0.000284574 | 1.51000 | *** |
| Methyl Palmitoleate | 740 | 18.258 | 4.88292E-05 | 0.000690577 | 1.16641 | *** |
| 8-Aminocaprylic acid | 734 | 18.511 | 0.002636825 | 4.89435E-11 | 1.54253 | *** |
| Gly-Pro | 867 | 18.984 | 8.3268E-05 | 0.000492377 | 1.51841 | *** |
| xanthine | 913 | 19.307 | 0.000738454 | 4.89435E-11 | 1.54224 | ** |
| N-Acetyl-D-galactosamine | 920 | 19.958 | 0.000980973 | 0.001963837 | 1.39968 | *** |
| 5-Methoxytryptamine | 649 | 23.263 | 0.000471539 | 0.000281012 | 1.07002 | ** |
| DL-dihydrosphingosine | 909 | 23.535 | 0.000341501 | 0.00271986 | 1.46487 | *** |
| adenosine | 640 | 24.531 | 3.20881E-05 | 6.79893E-05 | 1.32913 | *** |
| Monoolein | 662 | 25.420 | 2.73317E-05 | 7.12348E-06 | 1.48583 | *** |
aRentention time.
bStudent t-test of the relative levels of compounds detected in weaned and nursing piglets(n = 6). *p < 0.05, **p < 0.01 and ***p < 0.001, respectively.
Pathway analysis for nursing group and weaned group.
| Pathway | Totala | Hitsb | Raw pc | -ln(p)d | Holm adjuste | FDRf | Impactg |
|---|---|---|---|---|---|---|---|
| Beta-Alanine metabolism | 17 | 6 | 0.0012 | 6.7056 | 0.0992 | 0.0992 | 0.6667 |
| Arginine and proline metabolism | 44 | 9 | 0.0055 | 5.2020 | 0.4404 | 0.1825 | 0.3289 |
| Alanine, aspartate and glutamate metabolism | 23 | 6 | 0.0068 | 4.9967 | 0.5340 | 0.1825 | 0.4633 |
| Nitrogen metabolism | 9 | 3 | 0.0277 | 3.5847 | 1 | 0.5618 | 0 |
| Valine, leucine and isoleucine biosynthesis | 11 | 3 | 0.0486 | 3.0246 | 1 | 0.6558 | 0.6667 |
| D-Glutamine and D-glutamate metabolism | 5 | 2 | 0.0520 | 2.9559 | 1 | 0.6558 | 0 |
| Aminoacyl-tRNA biosynthesis | 64 | 9 | 0.0567 | 2.8704 | 1 | 0.6558 | 0 |
| Glycine, serine and threonine metabolism | 32 | 5 | 0.0991 | 2.3117 | 1 | 0.9605 | 0.3528 |
| Pantothenate and CoA biosynthesis | 15 | 3 | 0.1067 | 2.2375 | 1 | 0.9605 | 0.0408 |
| Phenylalanine metabolism | 9 | 2 | 0.1526 | 1.8796 | 1 | 1 | 0.2222 |
| Butanoate metabolism | 20 | 3 | 0.2024 | 1.5974 | 1 | 1 | 0.0290 |
| Ubiquinone and other terpenoid-quinone biosynthesis | 3 | 1 | 0.2173 | 1.5265 | 1 | 1 | 0 |
| Tyrosine metabolism | 42 | 5 | 0.2280 | 1.4783 | 1 | 1 | 0.0532 |
| Histidine metabolism | 14 | 2 | 0.3012 | 1.1999 | 1 | 1 | 0.2662 |
| Pyrimidine metabolism | 37 | 4 | 0.3286 | 1.1129 | 1 | 1 | 0.0634 |
| Pentose and glucuronate interconversions | 15 | 2 | 0.3311 | 1.1052 | 1 | 1 | 0 |
| Glutathione metabolism | 26 | 3 | 0.3336 | 1.0978 | 1 | 1 | 0.0057 |
| Cyanoamino acid metabolism | 6 | 1 | 0.3877 | 0.9475 | 1 | 1 | 0 |
| Biosynthesis of unsaturated fatty acids | 42 | 4 | 0.4210 | 0.8651 | 1 | 1 | 0 |
| Pentose phosphate pathway | 19 | 2 | 0.4461 | 0.8072 | 1 | 1 | 0.1209 |
| Propanoate metabolism | 20 | 2 | 0.4732 | 0.7483 | 1 | 1 | 0 |
| Citrate cycle (TCA cycle) | 20 | 2 | 0.4732 | 0.7483 | 1 | 1 | 0.1398 |
| Sphingolipid metabolism | 21 | 2 | 0.4995 | 0.6942 | 1 | 1 | 0.0526 |
| Methane metabolism | 9 | 1 | 0.5213 | 0.6515 | 1 | 1 | 0 |
| Vitamin B6 metabolism | 9 | 1 | 0.5213 | 0.6515 | 1 | 1 | 0 |
| Valine, leucine and isoleucine degradation | 38 | 3 | 0.5838 | 0.5383 | 1 | 1 | 0 |
| Riboflavin metabolism | 11 | 1 | 0.5938 | 0.5212 | 1 | 1 | 0 |
| Steroid hormone biosynthesis | 67 | 5 | 0.6158 | 0.4849 | 1 | 1 | 0.0541 |
| Nicotinate and nicotinamide metabolism | 13 | 1 | 0.6555 | 0.4223 | 1 | 1 | 0 |
| Primary bile acid biosynthesis | 46 | 3 | 0.7143 | 0.3365 | 1 | 1 | 0.0667 |
| Purine metabolism | 68 | 4 | 0.7967 | 0.2274 | 1 | 1 | 0.0269 |
| Lysine degradation | 20 | 1 | 0.8068 | 0.2147 | 1 | 1 | 0 |
| Pyruvate metabolism | 22 | 1 | 0.8363 | 0.1788 | 1 | 1 | 0.1875 |
| Starch and sucrose metabolism | 23 | 1 | 0.8493 | 0.1633 | 1 | 1 | 0 |
| Porphyrin and chlorophyll metabolism | 25 | 1 | 0.8724 | 0.1365 | 1 | 1 | 0 |
| Galactose metabolism | 26 | 1 | 0.8826 | 0.1250 | 1 | 1 | 0.0161 |
| Glycolysis or Gluconeogenesis | 26 | 1 | 0.8826 | 0.1250 | 1 | 1 | 0.0989 |
| Cysteine and methionine metabolism | 28 | 1 | 0.9006 | 0.1047 | 1 | 1 | 0.0210 |
| Glycerophospholipid metabolism | 29 | 1 | 0.9085 | 0.0960 | 1 | 1 | 0 |
| Steroid biosynthesis | 35 | 1 | 0.9446 | 0.0570 | 1 | 1 | 0.0539 |
| Amino sugar and nucleotide sugar metabolism | 37 | 1 | 0.9532 | 0.0480 | 1 | 1 | 0 |
| Fatty acid metabolism | 39 | 1 | 0.9604 | 0.0404 | 1 | 1 | 0 |
aThe number of metabolites in the pathway.
bThe number of differential metabolites that hit the pathway.
cThe P value of Metabolic pathway enrichment analysis.
dThe P value of Multiple Hypothesis Test Corrected by Holm-Bonferroni Method.
eThe P values of Multiple Hypothesis Tests for Corrected via the false discovery rate (FDR) Method.
fThe Impact value of metabolic pathway topology analysis.